1. Home
  2. KPTI vs MRBK Comparison

KPTI vs MRBK Comparison

Compare KPTI & MRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$9.02

Market Cap

194.8M

Sector

Health Care

ML Signal

HOLD

Logo Meridian Corporation

MRBK

Meridian Corporation

HOLD

Current Price

$18.08

Market Cap

206.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KPTI
MRBK
Founded
2008
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
194.8M
206.1M
IPO Year
2013
2018

Fundamental Metrics

Financial Performance
Metric
KPTI
MRBK
Price
$9.02
$18.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
4
Target Price
$16.00
$20.75
AVG Volume (30 Days)
434.6K
87.1K
Earning Date
05-04-2026
04-23-2026
Dividend Yield
N/A
3.05%
EPS Growth
N/A
30.34
EPS
N/A
0.17
Revenue
$146,067,000.00
$6,316,000.00
Revenue This Year
N/A
$25.40
Revenue Next Year
$22.36
$8.15
P/E Ratio
N/A
$104.71
Revenue Growth
0.57
10.13
52 Week Low
$3.65
$11.17
52 Week High
$10.99
$21.59

Technical Indicators

Market Signals
Indicator
KPTI
MRBK
Relative Strength Index (RSI) 58.40 48.67
Support Level $5.43 $16.96
Resistance Level $9.32 $18.13
Average True Range (ATR) 0.81 0.42
MACD 0.07 0.12
Stochastic Oscillator 66.13 85.93

Price Performance

Historical Comparison
KPTI
MRBK

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

About MRBK Meridian Corporation

Meridian Corp is a bank holding company based in the United States. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal and business lending and deposit services. It operates in three reportable segments, including Bank, Wealth, and Mortgage. Meridian generates maximum revenue from the Bank segment, which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans. Geographically, it operates in Pennsylvania, New Jersey, and Delaware, as well as in the Central Maryland market and southwest Florida, U.S.

Share on Social Networks: